Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2015-08-06

Clinical Trial Update: Effects of Zinc Supplementation on Anthropometric Factors, Apelin and Inflammatory Markers in Obese Individuals [Phase 2, Phase 3]

View source ↗

Summary

A Phase 2/Phase 3 trial evaluating the effects of zinc supplementation on anthropometric measures, apelin, and inflammatory markers in obese adults has complete…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Zinc supplementation (zinc)

Snippet

Sponsor: National Nutrition and Food Technology Institute | Conditions: Obesity | Phase 2, Phase 3 | Status: COMPLETED